Apr 7, 2026 07:01AM Precigen expects first quarter revenue to exceed $18 million

Apr 7, 2026 07:00AM Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million

Mar 26, 2026 06:43AM Precigen Inc. (PGEN) PT Raised to $10 at H.C. Wainwright

Mar 26, 2026 04:52AM Precigen Inc. (PGEN) PT Raised to $9 at Citizens- PAPZIMEOS Can Dominate RRP Market

Jan 20, 2026 08:06AM Medical experts recommend PAPZIMEOS as first-line RRP treatment, Precigen says

Jan 12, 2026 08:04AM Precigen reports 200 patients enrolled for FDA-approved RRP therapy

Nov 14, 2025 06:01AM Precigen's (PGEN) PAPZIMEOS Has Rapid Adoption Potential - Citizens

Nov 13, 2025 04:36PM Precigen Inc. (PGEN) Misses Q3 EPS by 97c

Oct 13, 2025 07:01AM Precigen reports sustained responses for RRP therapy PAPZIMEOS

Sep 26, 2025 06:44AM Cantor Fitzgerald Reiterates Overweight Rating on Precigen Inc. (PGEN)

Sep 3, 2025 07:00AM Precigen secures up to $125 million credit facility with Pharmakon

Aug 21, 2025 10:11AM Increasing unusual call option volume: PGEN EXE MNSO DUST REAL XME CARR HE GDRX INDA SPGI

Aug 19, 2025 06:57AM Cantor Fitzgerald Reiterates Overweight Rating on Precigen Inc. (PGEN)

Aug 19, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Precigen Inc. (PGEN)

Aug 18, 2025 04:00PM Precigen Inc. (PGEN) PT Raised to $8 at Citizens JMP

Jun 12, 2025 04:16AM Citizens JMP Reiterates Market Outperform Rating on Precigen Inc. (PGEN)

May 15, 2025 07:22AM Cantor Fitzgerald Reiterates Overweight Rating on Precigen Inc. (PGEN)

May 15, 2025 04:17AM Citizens JMP Reiterates Market Outperform Rating on Precigen Inc. (PGEN)

May 14, 2025 04:06PM Precigen Inc. (PGEN) Misses Q1 EPS by 10c

Mar 20, 2025 08:36AM Stifel Reiterates Buy Rating on Precigen Inc. (PGEN)

Mar 20, 2025 08:13AM Cantor Fitzgerald Reiterates Overweight Rating on Precigen Inc. (PGEN)

Mar 20, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Precigen Inc. (PGEN)

Feb 25, 2025 09:10AM Stifel Reiterates Buy Rating on Precigen Inc. (PGEN)

Feb 25, 2025 08:05AM Precigen Inc. (PGEN) Granted FDA Priority Review for PRGN-2012

Feb 19, 2025 10:17AM Increasing unusual call option volume: INFY CSGP BMBL GLBE WIX DB PGEN

Jan 2, 2025 04:00PM Biotech outlook for 2025: Stifel

Jan 2, 2025 10:56AM Stifel Highlights Iovanace Biotherapeutics (IOVA) as 'Top Pick' in Biotech's 2025 Outlook Note

Dec 27, 2024 09:00AM Precigen Inc. (PGEN) Announces $79M Placement of Convertible Preferred Stock

Nov 14, 2024 04:40PM Precigen Inc. (PGEN) Misses Q3 EPS by 1c

Aug 15, 2024 06:41AM Precigen Inc. (PGEN) PT Lowered to $4 at H.C. Wainwright

Aug 14, 2024 04:09PM Precigen Inc. (PGEN) Misses Q2 EPS by 13c, Misses on Revenue

Aug 8, 2024 06:22AM Precigen Inc. (PGEN) Prices 35.29M Share Offering at $0.85/sh

Aug 6, 2024 04:08PM Precigen Inc. (PGEN) Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch

Aug 6, 2024 04:04PM Precigen Inc. (PGEN) Announces Proposed $30M Share Offering

Jul 23, 2024 08:01AM Precigen Inc. (PGEN) Appoints Phil Tennant as Chief Commercial Officer